The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hackett, J.
Right arrow Articles by Kumar, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hackett, J., Jr
Right arrow Articles by Kumar, V.

The Journal of Immunology, Vol 134, Issue 6 3731-3738, Copyright © 1985 by American Association of Immunologists


ARTICLES

Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor

J Hackett Jr, M Bennett and V Kumar

To study the origin and differentiation of natural killer (NK) cells, we developed an assay for the transplantable precursor of NK(YAC-1) cells present in the bone marrow. Mice were depleted of endogenous NK(YAC-1) cells by injection of anti-asialo GM1 antibody, followed by lethal whole body irradiation. Normal syngeneic bone marrow cells were transplanted into such pretreated mice. Regeneration of NK(YAC-1) activity in the recipient mice was monitored by two different assays: the ability of spleen cells to lyse YAC-1 cells in vitro and the ability to clear i.v. injected, 125IUdR-labeled YAC-1 cells from the lungs. With both assays, a dose-response relationship between the number of bone marrow cells injected and the degree of NK(YAC-1) activity generated could be demonstrated. However, the lung clearance assay appeared superior because the NK regeneration could be detected earlier and with lower numbers of injected marrow cells. With this assay, several characteristics of the NK precursors and their differentiation could be defined. 1) The generation of mature, lytic NK cells from their transplantable precursor requires an intact "marrow microenvironment" in the recipient mice, because differentiation failed to occur in mice rendered osteopetrotic by estradiol treatment. 2) The NK(YAC-1) precursors lack the surface antigens (NK-2.1, asialo GM1, Qa- 5, Thy-1) that are characteristically seen on mature NK cells. 3) The NK-precursors could be eliminated from the bone marrow with anti-Qa-2 or anti-H-2 antisera + complement, indicating that these two antigens are expressed on the precursors. The relationship between NK(YAC-1) precursors and multipotent myeloid stem cells (CFU-S) was investigated by utilizing W/Wv and Sl/Sld mutant mice. Bone marrow cells of W/Wv anemic mice, although markedly deficient in CFU-S, have a normal frequency of NK(YAC-1) precursors. Sl/Sld mice that lack a suitable microenvironment for the development of CFU-S allowed normal differentiation of NK(YAC-1) precursors when transplanted with normal bone marrow cells. Together, these data suggest that multipotent myeloid progenitor cells, as defined by the CFU-S assay, and the NK(YAC- 1) precursors are not closely related.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Regunathan, Y. Chen, S. Kutlesa, X. Dai, L. Bai, R. Wen, D. Wang, and S. Malarkannan
Differential and Nonredundant Roles of Phospholipase C{gamma}2 and Phospholipase C{gamma}1 in the Terminal Maturation of NK Cells
J. Immunol., October 15, 2006; 177(8): 5365 - 5376.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. O. Richards, X. Chang, B. W. Blaser, M. A. Caligiuri, P. Zheng, and Y. Liu
Tumor growth impedes natural-killer-cell maturation in the bone marrow
Blood, July 1, 2006; 108(1): 246 - 252.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. S. Palumbo, K. E. Talmage, J. V. Massari, C. M. La Jeunesse, M. J. Flick, K. W. Kombrinck, M. Jirouskova, and J. L. Degen
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
Blood, January 1, 2005; 105(1): 178 - 185.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Taylor, P. M. Chaudhary, J. Klem, V. Kumar, J. D. Schatzle, and M. Bennett
Inhibition of the Death Receptor Pathway by cFLIP Confers Partial Engraftment of MHC Class I-Deficient Stem Cells and Reduces Tumor Clearance in Perforin-Deficient Mice
J. Immunol., October 15, 2001; 167(8): 4230 - 4237.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Hui Jia, Z. Kurepa, A. Bai, and J. Forman
Comparative Ability of Qdm/Qa-1b, Kb, and Db to Protect Class Ilow Cells from NK-Mediated Lysis In Vivo
J. Immunol., December 1, 2000; 165(11): 6142 - 6147.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Austin Taylor, M. Bennett, V. Kumar, and J. D. Schatzle
Functional Defects of NK Cells Treated with Chloroquine Mimic the Lytic Defects Observed in Perforin-Deficient Mice
J. Immunol., November 1, 2000; 165(9): 5048 - 5053.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. S. Williams, J. Klem, I. J. Puzanov, P. V. Sivakumar, M. Bennett, and V. Kumar
Differentiation of NK1.1+, Ly49+ NK Cells from flt3+ Multipotent Marrow Progenitor Cells
J. Immunol., September 1, 1999; 163(5): 2648 - 2656.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Corrections for vol. 184, p. 1845
J. Exp. Med., March 17, 1997; 185(6): 1149 - 1150.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Kim, K. Iizuka, H. L. Aguila, I. L. Weissman, and W. M. Yokoyama
In vivo natural killer cell activities revealed by natural killer cell-deficient mice
PNAS, March 14, 2000; 97(6): 2731 - 2736.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1985 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1985 by The American Association of Immunologists, Inc. All rights reserved.